Neither YKL-40 nor IL-6 is a cancer-specific biomarker, and both are produced by cancer cells and inflammatory cells and are biomarkers of inflammation and tissue remodeling [3], [5], [6], [14], [15], [41]–[43]. This evidence concerns the gene CHI3L1 and cancer.